Entity

Time filter

Source Type

Haifa, Israel

Cohen-Mansfield J.,Tel Aviv University | Juravel-Jaffe A.,Maccabi Health Services | Cohen A.,Israel Ministry of Health | Cohen A.,Mount Scopus Hadassah University Hospital | And 2 more authors.
International Psychogeriatrics | Year: 2013

Background: To clarify physicians' actual practice in treating agitation in the nursing home and to elucidate the relationship between background factors, familiarity with interventions, and practice. Methods: A survey of actual practice for agitation in persons with dementia was administered to 67 physicians aged 31-70+ working in nursing homes in Israel. Questionnaires were administered by personal interview, self-completed, or a combination of the two. Results: Psychotropic medications are prescribed by 92.5% of physicians for treating agitation, most notably, Haloperidol (39%). Non-pharmacological treatment was also reported to be common, though to a lesser extent, with environmental change being the most prevalent non-pharmacological intervention. Generally, physicians showed low familiarity levels with non-pharmacological interventions, with higher levels noted for physicians with a specialty in geriatrics compared to those who were non-specialized. Physicians who were non-Israeli and younger also reported higher familiarity levels compared to their respective counterparts (i.e. Israeli and older) but this difference did not reach significance. Conclusion: The findings indicate that, despite current guidelines, psychotropic medications are the treatment of choice among nursing home physicians in Israel. While rates of use of non-pharmacological interventions are substantial, their in-practice application may be hindered by lack of familiarity as well as system barriers. The results have implications for system and education changes. © 2012 International Psychogeriatric Association. Source


Shapira M.,Maccabi Health Services
Pediatric Dermatology | Year: 2014

Oral mucoceles are common lesions that normally appear in the second decade of life. They are uncommon in neonates and infants. We present a case of a mucocele in a 10-month-old infant and review the literature regarding the epidemiology and treatment in this age group. © 2013 Wiley Periodicals, Inc. Source


Vakhapova V.,Maccabi Health Services | Cohen T.,Enzymotec | Richter Y.,Enzymotec | Herzog Y.,Enzymotec | And 2 more authors.
Dementia and Geriatric Cognitive Disorders | Year: 2014

Background: The present study is an open-label extension (OLE) aimed at evaluating the effect of 100 mg/day of phosphatidylserine enriched with docosahexaenoic acid (PS-DHA) on cognitive performance in nondemented elderly individuals with memory complaints. Methods: From the participants who completed the core study, 122 continued with a 15-week OLE. Efficacy was assessed using a computerized tool and the Clinical Global Impression of Change (CGI-C) rating scale. Results: A significant improvement in sustained attention and memory recognition was observed in the PS-DHA naïve group, while the PS-DHA continuers maintained their cognitive status. Additionally, a significant improvement in CGI-C was observed in the naïve group. Conclusions: The results demonstrate that consumption of 100 mg/day of PS-DHA might be associated with improving or maintaining cognitive status in elderly subjects with memory complaints. © 2014 S. Karger AG, Basel. Source


Weissenberg R.,Maccabi Health Services | Landau R.,Hebrew University of Jerusalem
American Journal of Orthopsychiatry | Year: 2012

This study follows 40 older single-mother families created with the aid of sperm donation using either insemination or in vitro fertilization. The study is based on qualitative data obtained from the mothers 3years after a previous study with these families. The mean age of the mothers at this time was about 47years and of the children 7years. The findings provide insights into the mothers' and children's current sociodemographic characteristics, physical health, socioemotional development and the children's reactions to the absence of a father at follow-up time. The majority of the children raised by these older single mothers have good health. The salient result is that at follow-up, 45% of these older single-mother families comprise a family unit with more than 1 child, clearly demonstrating these families' desire for a larger family than a mother-child unit. The desire and attempts of the mothers in the sample to give birth to additional children using assisted conception demonstrate the divergence in the fertility patterns of Israeli society from other developed countries. © 2012 American Orthopsychiatric Association. Source


Golubchik P.,Geha Mental Health Center | Golubchik P.,Tel Aviv University | Kodesh A.,Maccabi Health Services | Kodesh A.,Haifa University | And 2 more authors.
Clinical Neuropharmacology | Year: 2013

BACKGROUND: Youths with attention-deficit/hyperactivity disorder (ADHD) may develop demoralization or depressive or dysthymic symptoms related to chronic social, familial, and academic difficulties that are associated with their ADHD and are at higher risk for developing mood disorders. We assessed the effectiveness of methylphenidate (MPH) on both ADHD and mood symptoms in children and adolescents diagnosed with ADHD and coexistent subsyndromal depression (SSD). METHODS: A group of ADHD patients with SSD (n = 47), aged 8 to 18 years, received 12 weeks of MPH treatment. The severity of depressive and ADHD symptoms was assessed using the Child Depression Rating Scale (CDRS) and the Attention Deficit/Hyperactivity Disorder Rating Scale (ADHD-RS), respectively. RESULTS: A highly significant decrease in both ADHD-RS and CDRS scores was obtained in the total group (N = 47) after MPH treatment (P = 0.0001 and P = 0.0001, respectively). A significant positive correlation was found between the changes in the CDRS total scores and the ADHD-RS (r = 0.34, N = 47, P = 0.018). However, no such correlation was found in a subgroup (N = 8) of patients with "possible depression" (baseline CDRS score, 65-74; r = 0.026, P = 0.95). CONCLUSIONS: Methylphenidate treatment is effective for both ADHD and SSD symptoms. It seems that ADHD symptoms are less responsive to MPH in patients with relatively high CDRS scores (possible depression) and that those patients may be candidates for selective serotonin reuptake inhibitor treatment as a supplement for MPH. Further, larger, placebo-controlled, double-blind studies are needed to examine the impact of MPH or d-amphetamine on patients with ADHD/SSD and ADHD/major depressive disorder.© 2013 by Lippincott Williams & Wilkins. Source

Discover hidden collaborations